BNET Industries
Last Fiscal Year Sales:$37.5M
- Private
- US
Dow Jones Description
To become a key supplier of defined biochemicals, reagents and services, to the life-science and selected industries. We will accomplish this by earning customer trust and loyalty and applying our knowledge and capabilities to achieve their total satisfaction.
Number of Employees 180
Peer Companies
NAICS Code Medicinal and Botanical Manufacturing: 325411
News & Analysis
Filter by
amresco inc. and fitch ratings - All News and Analysis
Fitch Takes Rating Actions on Amresco Transactions
CHICAGO -- Fitch Ratings has taken the following rating actions on the ACLC Franchise Loan Receivables Trusts and ACLC Business Loan Receivables Trusts listed below: ACLC Franchise Loan Receivables Trust 1997-A: --Class A-1 currently rated at 'AAA' and remains on Rating Watch Negative; --Class A-2 currently rated...
Fitch Ratings Affirms AMRESCO 1997-C1
CHICAGO -- Fitch Ratings has affirmed AMRESCO Commercial Mortgage Funding I Corp.'s, mortgage pass-through certificates, series 1997-C1, as follows: --Interest-only class X at 'AAA'; --$2.6 million class G at 'AAA'; --$4.8 million class H at 'A+'; --$7.2 million class J at 'BB+'; --$2.4 million class...
Fitch Ratings Affirms AMRESCO 1997-C1
CHICAGO -- Fitch affirms AMRESCO Commercial Mortgage Funding I Corp.'s, mortgage pass-through certificates, series 1997-C1, as follows: --Interest-only class X at 'AAA'; --$5.9 million class E at 'AAA'; --$9.6 million class F at 'AAA'; --$31.2 million class G at 'AAA'; --$4.8 million class H at...
AMRESCO, Series 1997-C1 Upgraded by Fitch Ratings
NEW YORK -- AMRESCO Commercial Mortgage Funding I Corp.'s, mortgage pass-through certificates, series 1997-C1, are upgraded by Fitch Ratings as follows: -- $31.2 million class G to 'BBB' from 'BBB-'. The following classes are affirmed by Fitch: -- $33 million class A-3 'AAA'; -- Interest-only class...
Fitch Lowers 1 & Affirms 18 RMBS Classes from 3 AMRESCO Transactions
NEW YORK -- Fitch Ratings has affirmed 18 and downgraded one class from the following AMRESCO Residential Securities Corp. issues: Series 1998-1 Group 1 -- Class A-5, A-6 affirmed at 'AAA'; -- Class M-1F affirmed at 'AA'; -- Class M-2F affirmed at 'A'. Series 1998-1...
Fitch Takes Ratings Actions on Amresco Franchise Transactions
CHICAGO -- Fitch Ratings has taken ratings actions on the following issues for ACLC Franchise Loan Receivables Trusts and ACLC Business Loan Receivables Trusts: ACLC Franchise Loan Receivables Trust 1997-A: Class A-1 affirmed at 'AAA'; Class A-2 affirmed at 'AAA'. *Both affirmations are based on the...
AMRESCO Series 1997-C1 Upgraded by Fitch Ratings
NEW YORK -- AMRESCO Commercial Mortgage Funding I Corp.'s mortgage pass-through certificates, series 1997-C1, are upgraded by Fitch Ratings as follows: --$9.6 million class F to 'AAA' from 'AA+'. The following classes are affirmed by Fitch: --$67.2 million class A-3 'AAA'; --Interest-only class X 'AAA'; ...
Fitch Takes Rating Actions On 4 AMRESCO RMBS Securitizations
NEW YORK -- Fitch Ratings has upgraded two, affirmed 27, and downgraded two one of which was on Rating Watch Negative classes from the following AMRESCO issues: Series 1997-1 Group 1 -- Class A-7 - A-8 affirmed at 'AAA'; -- Class M-1F affirmed at 'AA'; --...
Fitch Ratings Affirms AMRESCO, Series 1997-C1
Business Editors NEW YORK--BUSINESS WIRE--July 22, 2002 AMRESCO Commercial Mortgage Funding I Corp., mortgage pass-through certificates, series 1997-C1, $60.0 million class A-1, $40.0 million class A-2, $141.6 million class A-3, and interest-only class X are affirmed at 'AAA' by Fitch Ratings. In addition, the $24.0 million class B...
Fitch Ratings Downgrades Certain Amresco Franchise Transactions
Business Editors NEW YORK--BUSINESS WIRE--May 10, 2002 Fitch Ratings downgrades ACLC Business Loan Receivables Trust 1998-1 class A-1 to 'AA' from 'AAA', class A-2 to 'BBB' from 'AA' and class A-3 to 'BB-' from 'A'. The downgrade is a result of continued deterioration in collateral quality and anticipated...
- 1
Decision Makers
| Name (plus bio) | Position |
|---|---|
| David Camiener | CEO |
| Ron Centa | Marketing Executive |
| Organization | Position | Status |
|---|---|---|
| Amresco Inc. | CEO | Current |
| Amresco Inc. | President | Former |
| Organization | Position | Status |
|---|---|---|
| Amresco Inc. | Marketing Executive | Current |
Industry Transcripts by Seeking Alpha
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
-
InterMune, Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ITMN
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- More Tysabri Problems; Time for a Biogen-Idec Credibility Check 3 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes
- Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching 3 votes
- VeriChip TV Ad Confirms Critics' Fears: They Want Everyone Implanted 3 votes

